Comparative Efficacy and Safety of Immunosuppressive Strategies in Kidney Transplantation: A Network Meta-analysis

Network meta-analyses comparing immunosuppressive strategies in kidney transplantation indicate that lymphocyte-depleting induction agents such as alemtuzumab and rabbit antithymocyte globulin reduce acute rejection more than interleukin-2 receptor antagonists, but at the cost of more infectious complications.